Depot Naltrexone Treatment of Opioid Dependent Parolees

Summary

This is an investigation involving the use of a long-acting, injectable form (depot) of naltrexone as a treatment for persons who have a history of opioid dependence, with up to 40 on parole/probation and 20 non-parolees. The test is a pilot study of up to 60 subjects treated with 6 months of depot naltrexone plus Psychosocial Treatment .

Timeline

Start

2005-11

Primary completion

2009-03

Completion

2011-08

Drugs

Indications